TMCnet News
30.1% Return Seen to Date on SmarTrend Nektar Therapeutics Call (NKTR)Feb 28, 2013 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Nektar Therapeutics (NASDAQ:NKTR) on December 11th, 2012 at $7.15. In approximately 3 months, Nektar Therapeutics has returned 30.07% as of today's recent price of $9.30. Nektar Therapeutics share prices have moved between a 52-week high of $10.98 and a 52-week low of $5.65 and are now trading 65% above that low price at $9.30 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.7% while the 200-day MA has risen 0.4%. Nektar Therapeutics (Nektar) is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Nektar's research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient. SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Nektar Therapeutics shares.Log in and add Nektar Therapeutics (NKTR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |